Jun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jun Liu has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Riming Huang
Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science South China Agricultural University Guangzhou China
7 shared publications - Xiaoyong Zhang
University Joint Laboratory of Guangdong Province, Hong Kong and Macao Region on Marine Bioresource Conservation and Exploitation, College of Marine Sciences, South China Agricultural University, Guangzhou 510642, China
4 shared publications - Huili Hao
Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, Guangzhou 510642, China
3 shared publications - Xuewei Xia
Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, Guangzhou, China
3 shared publications Yi Zhao
Laboratory of Pathogenic Biology, Guangdong Medical University, Zhanjiang, China
3 shared publications- Yulin Wu
Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, Guangzhou 510642, China
3 shared publications
Latest Publications
- Open Access
- 7 February 2026
- Published by Springer Nature in BMC Genomics
- Vol. 27 (1)
Rapid growth phenotype of carbapenem-resistant Enterobacter cloacae: growth fitness, stability, and mechanistic insights
The continued rise in carbapenem-resistant Enterobacter cloacae (CREC) detections indicates that current control measures are insufficient, potentially due
- 7 February 2026
- Published by Springer Nature in BMC Genomics
- Vol. 27 (1)
Open AccessRapid growth phenotype of carbapenem-resistant Enterobacter cloacae: growth fitness, stability, and mechanistic insights
The continued rise in carbapenem-resistant Enterobacter cloacae (CREC) detections indicates that current control measures are insufficient, potentially due
- Open Access
- 1 December 2025
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 15 (1) , 66
Preparation, physicochemical properties, and immunomodulatory activity of glycoproteins from Syngnathoides biaculeatus
Syngnathoides biaculeatus , a potential functional food from marine sources, was found to enhance nonspecific immunity, but its functional ingredients have rarely been reported. Therefore, this study focused on the preparation and physicochemical properties of its water-soluble natural ingredients with their immunomodulatory activities and potential mechanisms. Firstly, we optimized the extraction method of glycoproteins from S. biaculeatus and prepared the crude glycoprotein SYB, from which the fraction glycoprotein SYB-1 was further purified. The carbohydrates of SYB-1 were 8.46% comprising mannose, glucose, and galactose, with an average molecular weight of 9.423 kDa. Amino acid analysis demonstrated that its major amino acids are glycine, glutamic acid, aspartic acid, and proline, with a total amino acid content of 88.81%. Furthermore, SYB-1 could significantly increase the cell viability of macrophages, and promote the release of NO, TNF- α , and IL-6. Metabolomics revealed that it was associated with arachidonic acid metabolism. The CYP450 enzyme family members and PTGS2 may be key targets for the regulatory role. These results suggested that the glycoprotein of S. biaculeatus may be an attractive functional food supplement from natural sources for immunocompromised populations. Graphical Abstract
- 1 December 2025
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 15 (1) , 66
Open AccessPreparation, physicochemical properties, and immunomodulatory activity of glycoproteins from Syngnathoides biaculeatus
Syngnathoides biaculeatus , a potential functional food from marine sources, was found to enhance nonspecific immunity, but its functional ingredients have rarely been reported. Therefore, this study focused on the preparation and physicochemical properties of its water-soluble natural ingredients with their immunomodulatory activities and potential mechanisms. Firstly, we optimized the extraction method of glycoproteins from S. biaculeatus and prepared the crude glycoprotein SYB, from which the fraction glycoprotein SYB-1 was further purified. The carbohydrates of SYB-1 were 8.46% comprising mannose, glucose, and galactose, with an average molecular weight of 9.423 kDa. Amino acid analysis demonstrated that its major amino acids are glycine, glutamic acid, aspartic acid, and proline, with a total amino acid content of 88.81%. Furthermore, SYB-1 could significantly increase the cell viability of macrophages, and promote the release of NO, TNF- α , and IL-6. Metabolomics revealed that it was associated with arachidonic acid metabolism. The CYP450 enzyme family members and PTGS2 may be key targets for the regulatory role. These results suggested that the glycoprotein of S. biaculeatus may be an attractive functional food supplement from natural sources for immunocompromised populations. Graphical Abstract
- Open Access
- 17 October 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 1-16
Characterization and transmission dynamics of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae isolated from eight teaching hospitals in Guangdong province, China (2022–2024)
The Corona Virus Disease 2019 (COVID-19) pandemic has introduced complex challenges in resistance and transmission. During the COVID-19 pandemic, increased antibiotic use, interruptions in healthcare services, and complex infections in patients can all promote the emergence and spread of drug-resistant bacteria. However, detailed investigations into the characteristics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) and the alterations in their transmission dynamics during the pandemic remain scarce. This study analyzed 54 CREC strains collected from eight teaching hospitals in Guangdong Province, China, between December 2022 and June 2024. The variable temperature Sodium Dodecyl Sulfate (SDS) plasmid elimination method and PCR were used to analyze the samples. The positive rate of CEGs was 85.19% (46/54). Among the 54 CREC isolates, 33.33% (18/54) carried the blaNDM−1 gene on both chromosomes and plasmids. A total of 46.30% (25/54) of the isolates had the blaNDM−1 gene exclusively on plasmids. Additionally, 3.70% (2/54) of the isolates harbored only the blaIMP gene on plasmids. Finally, 1.85% (1/54) of the isolates contained both the blaNDM−1 gene and blaKPC−2 gene on plasmids. The broth microdilution method showed that the resistance rate of CEG-positive group to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin and levofloxacin were significantly higher than those of CEG-Negative group (P<0.05). Plasmid conjugation experiments and PCR analysis revealed a 95.65% (44/46) success rate for the transfer of CEGs. Among these, the success rates for the blaNDM−1, blaIMP, and blaKPC−2 genes were 95.45% (42/44), 100.00% (2/2) and 0% (0/1) respectively. Six types of mobile genetic elements were identified, with ISEcp1 being the most prevalent (87.04%, 47/54). CREC carrying four types of mobile genetic elements simultaneously was the most prevalent (40.74%, 22/54). ERIC-PCR and NTSYS software categorized the 54 CREC strains into 17 genotypes, with type E and type G showing the highest prevalence (both of them 20.37%, 11/54), originating from different departments in five hospitals. Among the type E isolates, 3.70% (2/54) strains shared a Dice coefficient of 100%. The epidemiology of CEG shows that the detection rates of men, elderly people, respiratory medicine, and sputum samples are the highest in gender, age group, clinical department, and specimen category, accounting for 64.81% (35/54), 72.22% (39/54), 20.37% (11/54) and 33.33% (18/54), respectively. CREC plasmids and chromosomes frequently harbor CEGs, with the blaNDM−1 gene being a predominant example, particularly when located on plasmids. CEG-positive strains demonstrated significant levels of multidrug resistance. Furthermore, CEGs displayed a notable capacity for both horizontal and vertical dissemination. Higher detection frequencies of CEGs were identified in male patients, elderly individuals, within respiratory medicine contexts, and in sputum samples.
- 17 October 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 1-16
Open AccessCharacterization and transmission dynamics of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae isolated from eight teaching hospitals in Guangdong province, China (2022–2024)
The Corona Virus Disease 2019 (COVID-19) pandemic has introduced complex challenges in resistance and transmission. During the COVID-19 pandemic, increased antibiotic use, interruptions in healthcare services, and complex infections in patients can all promote the emergence and spread of drug-resistant bacteria. However, detailed investigations into the characteristics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) and the alterations in their transmission dynamics during the pandemic remain scarce. This study analyzed 54 CREC strains collected from eight teaching hospitals in Guangdong Province, China, between December 2022 and June 2024. The variable temperature Sodium Dodecyl Sulfate (SDS) plasmid elimination method and PCR were used to analyze the samples. The positive rate of CEGs was 85.19% (46/54). Among the 54 CREC isolates, 33.33% (18/54) carried the blaNDM−1 gene on both chromosomes and plasmids. A total of 46.30% (25/54) of the isolates had the blaNDM−1 gene exclusively on plasmids. Additionally, 3.70% (2/54) of the isolates harbored only the blaIMP gene on plasmids. Finally, 1.85% (1/54) of the isolates contained both the blaNDM−1 gene and blaKPC−2 gene on plasmids. The broth microdilution method showed that the resistance rate of CEG-positive group to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin and levofloxacin were significantly higher than those of CEG-Negative group (P<0.05). Plasmid conjugation experiments and PCR analysis revealed a 95.65% (44/46) success rate for the transfer of CEGs. Among these, the success rates for the blaNDM−1, blaIMP, and blaKPC−2 genes were 95.45% (42/44), 100.00% (2/2) and 0% (0/1) respectively. Six types of mobile genetic elements were identified, with ISEcp1 being the most prevalent (87.04%, 47/54). CREC carrying four types of mobile genetic elements simultaneously was the most prevalent (40.74%, 22/54). ERIC-PCR and NTSYS software categorized the 54 CREC strains into 17 genotypes, with type E and type G showing the highest prevalence (both of them 20.37%, 11/54), originating from different departments in five hospitals. Among the type E isolates, 3.70% (2/54) strains shared a Dice coefficient of 100%. The epidemiology of CEG shows that the detection rates of men, elderly people, respiratory medicine, and sputum samples are the highest in gender, age group, clinical department, and specimen category, accounting for 64.81% (35/54), 72.22% (39/54), 20.37% (11/54) and 33.33% (18/54), respectively. CREC plasmids and chromosomes frequently harbor CEGs, with the blaNDM−1 gene being a predominant example, particularly when located on plasmids. CEG-positive strains demonstrated significant levels of multidrug resistance. Furthermore, CEGs displayed a notable capacity for both horizontal and vertical dissemination. Higher detection frequencies of CEGs were identified in male patients, elderly individuals, within respiratory medicine contexts, and in sputum samples.
- Open Access
- 17 May 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (24) , 15133-15144
2-Methoxy-1,4-naphthoquinone regulated molecular alternation of Fusarium proliferatum revealed by high-dimensional biological data
Fungi Fusarium proliferatum and the toxins it produces are hazardous to agricultural plants, animals, and human health. The signaling pathways and biotargets of F. proliferatum triggered by MNQ were confirmed in this work.
- 17 May 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (24) , 15133-15144
Open Access2-Methoxy-1,4-naphthoquinone regulated molecular alternation of Fusarium proliferatum revealed by high-dimensional biological data
Fungi Fusarium proliferatum and the toxins it produces are hazardous to agricultural plants, animals, and human health. The signaling pathways and biotargets of F. proliferatum triggered by MNQ were confirmed in this work.
- Open Access
- 19 April 2022
- Published by Elsevier in Food Chemistry: X
- Vol. 14, 100313
A new polysaccharide from Caulerpa chemnitzia induces molecular shifts of immunomodulation on macrophages RAW264.7
- 19 April 2022
- Published by Elsevier in Food Chemistry: X
- Vol. 14, 100313
Open AccessA new polysaccharide from Caulerpa chemnitzia induces molecular shifts of immunomodulation on macrophages RAW264.7
- Open Access
- 31 January 2022
- Published by MDPI AG in Marine Drugs
- Vol. 20 (2) , 114
Molecular Details of Actinomycin D-Treated MRSA Revealed via High-Dimensional Data
Methicillin-resistant Staphylococcus aureus (MRSA) is highly concerning as a principal infection pathogen. The investigation of higher effective natural anti-MRSA agents from marine Streptomyces parvulus has led to the isolation of actinomycin D, that showed potential anti-MRSA activity with MIC and MBC values of 1 and 8 μg/mL, respectively. Proteomics-metabolomics analysis further demonstrated a total of 261 differential proteins and 144 differential metabolites induced by actinomycin D in MRSA, and the co-mapped correlation network of omics, indicated that actinomycin D induced the metabolism pathway of producing the antibiotic sensitivity in MRSA. Furthermore, the mRNA expression levels of the genes acnA, ebpS, clfA, icd, and gpmA related to the key differential proteins were down-regulated measured by qRT-PCR. Molecular docking predicted that actinomycin D was bound to the targets of the two key differential proteins AcnA and Icd by hydrogen bonds and interacted with multiple amino acid residues of the proteins. Thus, these findings will provide a basic understanding to further investigation of actinomycin D as a potential anti-MRSA agent.
- 31 January 2022
- Published by MDPI AG in Marine Drugs
- Vol. 20 (2) , 114
Open AccessMolecular Details of Actinomycin D-Treated MRSA Revealed via High-Dimensional Data
Methicillin-resistant Staphylococcus aureus (MRSA) is highly concerning as a principal infection pathogen. The investigation of higher effective natural anti-MRSA agents from marine Streptomyces parvulus has led to the isolation of actinomycin D, that showed potential anti-MRSA activity with MIC and MBC values of 1 and 8 μg/mL, respectively. Proteomics-metabolomics analysis further demonstrated a total of 261 differential proteins and 144 differential metabolites induced by actinomycin D in MRSA, and the co-mapped correlation network of omics, indicated that actinomycin D induced the metabolism pathway of producing the antibiotic sensitivity in MRSA. Furthermore, the mRNA expression levels of the genes acnA, ebpS, clfA, icd, and gpmA related to the key differential proteins were down-regulated measured by qRT-PCR. Molecular docking predicted that actinomycin D was bound to the targets of the two key differential proteins AcnA and Icd by hydrogen bonds and interacted with multiple amino acid residues of the proteins. Thus, these findings will provide a basic understanding to further investigation of actinomycin D as a potential anti-MRSA agent.
- Open Access
- 12 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12231
Multi-Omics Analysis Reveals Anti-Staphylococcus aureus Activity of Actinomycin D Originating from Streptomyces parvulus
Staphylococcus aureus (S. aureus) is a common pathogen that causes various serious diseases, including chronic infections. Discovering new antibacterial agents is an important aspect of the pharmaceutical field because of the lack of effective antibacterial drugs. In our research, we found that one anti-S. aureus substance is actinomycin D, originating from Streptomyces parvulus (S. parvulus); then, we further focused on the anti-S. aureus ability and the omics profile of S. aureus in response to actinomycin D. The results revealed that actinomycin D had a significant inhibitory activity on S. aureus with a minimum inhibitory concentration (MIC) of 2 μg/mL and a minimum bactericidal concentration (MBC) of 64 μg/mL. Bacterial reactive oxygen species (ROS) increased 3.5-fold upon treatment with actinomycin D, as was measured with the oxidation-sensitive fluorescent probe DCFH-DA, and H2O2 increased 3.5 times with treatment by actinomycin D. Proteomics and metabolomics, respectively, identified differentially expressed proteins in control and treatment groups, and the co-mapped correlation network of proteomics and metabolomics annotated five major pathways that were potentially related to disrupting the energy metabolism and oxidative stress of S. aureus. All findings contributed to providing new insight into the mechanisms of the anti-S. aureus effects of actinomycin D originating from S. parvulus.
- 12 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12231
Open AccessMulti-Omics Analysis Reveals Anti-Staphylococcus aureus Activity of Actinomycin D Originating from Streptomyces parvulus
Staphylococcus aureus (S. aureus) is a common pathogen that causes various serious diseases, including chronic infections. Discovering new antibacterial agents is an important aspect of the pharmaceutical field because of the lack of effective antibacterial drugs. In our research, we found that one anti-S. aureus substance is actinomycin D, originating from Streptomyces parvulus (S. parvulus); then, we further focused on the anti-S. aureus ability and the omics profile of S. aureus in response to actinomycin D. The results revealed that actinomycin D had a significant inhibitory activity on S. aureus with a minimum inhibitory concentration (MIC) of 2 μg/mL and a minimum bactericidal concentration (MBC) of 64 μg/mL. Bacterial reactive oxygen species (ROS) increased 3.5-fold upon treatment with actinomycin D, as was measured with the oxidation-sensitive fluorescent probe DCFH-DA, and H2O2 increased 3.5 times with treatment by actinomycin D. Proteomics and metabolomics, respectively, identified differentially expressed proteins in control and treatment groups, and the co-mapped correlation network of proteomics and metabolomics annotated five major pathways that were potentially related to disrupting the energy metabolism and oxidative stress of S. aureus. All findings contributed to providing new insight into the mechanisms of the anti-S. aureus effects of actinomycin D originating from S. parvulus.
- Open Access
- 25 June 2020
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (15) , 8763-8771
Antibacterial potential of Forsythia suspensa polysaccharide against resistant Enterobacter cloacae with SHV‐12 extended‐spectrum β‐lactamase (ESBL)
In this study, a homogenous polysaccharide (FSP), with an average molecular weight of 9.08 × 104 Da, was isolated from Forsythia suspense and its antibacterial potential against Enterobacter cloacae producing SHV‐12 ESBL was investigated. Growth kinetics, in vitro competition and biofilm formation experiments demonstrated that SHV‐12 ESBL contributed to a fitness benefit to E cloacae strain. The antibacterial activity of FSP (2.5, 5.0 and 10.0 μg/mL) was tested against E cloacae bearing SHV‐12 ESBL gene using bacterial sensitivity, agar bioassay and agar well diffusion assays. It was found that the addition of FSP demonstrated potent antibacterial activities against this bacterial as showed by the decrease of bacterial growth and the increase of the inhibition zone diameter. Furthermore, SHV‐12 ESBL gene expression was decreased in E cloacae strain following different FSP treatment in a concentration‐dependent manner. In conclusion, these data showed that FSP exhibited potent good antibacterial activity against E cloacae producing SHV‐12 ESBL via inhibition of SHV‐12 ESBL gene expression, which may promote the development of novel natural antibacterial agents to treat infections caused by this drug‐resistant bacterial pathogen.
- 25 June 2020
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (15) , 8763-8771
Open AccessAntibacterial potential of Forsythia suspensa polysaccharide against resistant Enterobacter cloacae with SHV‐12 extended‐spectrum β‐lactamase (ESBL)
In this study, a homogenous polysaccharide (FSP), with an average molecular weight of 9.08 × 104 Da, was isolated from Forsythia suspense and its antibacterial potential against Enterobacter cloacae producing SHV‐12 ESBL was investigated. Growth kinetics, in vitro competition and biofilm formation experiments demonstrated that SHV‐12 ESBL contributed to a fitness benefit to E cloacae strain. The antibacterial activity of FSP (2.5, 5.0 and 10.0 μg/mL) was tested against E cloacae bearing SHV‐12 ESBL gene using bacterial sensitivity, agar bioassay and agar well diffusion assays. It was found that the addition of FSP demonstrated potent antibacterial activities against this bacterial as showed by the decrease of bacterial growth and the increase of the inhibition zone diameter. Furthermore, SHV‐12 ESBL gene expression was decreased in E cloacae strain following different FSP treatment in a concentration‐dependent manner. In conclusion, these data showed that FSP exhibited potent good antibacterial activity against E cloacae producing SHV‐12 ESBL via inhibition of SHV‐12 ESBL gene expression, which may promote the development of novel natural antibacterial agents to treat infections caused by this drug‐resistant bacterial pathogen.
- Open Access
- 24 April 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (28) , 16339-16348
Structural features, interaction with the gut microbiota and anti-tumor activity of oligosaccharides
Some oligosaccharides are regarded as biological constituents with benefits to human health in an indirect way.
- 24 April 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (28) , 16339-16348
Open AccessStructural features, interaction with the gut microbiota and anti-tumor activity of oligosaccharides
Some oligosaccharides are regarded as biological constituents with benefits to human health in an indirect way.
- Open Access
- 31 October 2019
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 9 (61) , 35312-35327
Marine unsaturated fatty acids: structures, bioactivities, biosynthesis and benefits
Unsaturated fatty acids (UFAs) are an important category of monounsaturated and polyunsaturated fatty acids with nutritional properties.
- 31 October 2019
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 9 (61) , 35312-35327
Open AccessMarine unsaturated fatty acids: structures, bioactivities, biosynthesis and benefits
Unsaturated fatty acids (UFAs) are an important category of monounsaturated and polyunsaturated fatty acids with nutritional properties.